SDIC Power Holdings (600886.SH) plans to raise up to 7 billion yuan through a private placement to the Social Security Fund. The issuance price is set at 12.72 yuan per share.
Guotou Power (600886.SH) disclosed that in 2024 it will offer specific targets to the National Social Security Fund Council.
SDIC Power Holdings (600886.SH) disclosed a plan to privately issue A-shares to the National Social Security Fund Council (Social Security Fund) for the fiscal year 2024. The recipients of this issuance are the Social Security Fund, who will subscribe to the company's stock in RMB cash. Based on the proposed number of shares to be issued, after the issuance, the Social Security Fund will become a shareholder owning over 5% of the company's shares, making them a related party and the issuance a related transaction.
The issuance price for this offering is 12.72 yuan per share, and the number of shares to be issued is determined by dividing the total fundraising amount by the issuance price, with a proposed issuance of 550,314,465 shares, not exceeding 30% of the company's total shares before the issuance. The proposed fundraising amount for this offering is not more than 7.00 billion yuan, with the net proceeds, after deducting relevant issuance expenses, to be used entirely for clean energy project construction, as follows: 4.5 billion yuan for the Mengdihe Hydropower Station project, and 2.5 billion yuan for the Kara Hydropower Station project.
Related Articles

New stock news | PT Merdeka Gold Resources Tbk files for listing on the Hong Kong Stock Exchange

New stock news | New Element Pharma submits a second filing to the Hong Kong Stock Exchange. Its core product ABP-671 is a new generation URAT1 inhibitor.

New stock news | New Element Pharmaceuticals files for a second time with the Hong Kong Stock Exchange.
New stock news | PT Merdeka Gold Resources Tbk files for listing on the Hong Kong Stock Exchange

New stock news | New Element Pharma submits a second filing to the Hong Kong Stock Exchange. Its core product ABP-671 is a new generation URAT1 inhibitor.

New stock news | New Element Pharmaceuticals files for a second time with the Hong Kong Stock Exchange.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


